Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Redeemable Non-Controlling Interests and Stockholders' Equity

v3.21.1
Condensed Consolidated Statements of Changes in Redeemable Non-Controlling Interests and Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Redeemable non-controlling interests, beginning balance at Dec. 31, 2019 $ 31,616                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Distributions to redeemable non-controlling interests (112)                
Net income 435                
Redeemable non-controlling interests, ending balance at Mar. 31, 2020 31,939                
Beginning balance (in shares) at Dec. 31, 2019       29,230,005 18,000,000       2,101,340
Beginning balance at Dec. 31, 2019 428,856     $ 3 $ 2 $ 133,688 $ 314,459 $ (7,514) $ (11,782)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)       280,611          
Exercise of stock options 2,474         2,474      
Stock-based compensation expense 429         429      
Open market purchase of common shares (in shares)       (455)         455
Open market purchase of common shares (6)               $ (6)
Unrealized gain (loss) from interest rate hedges, net (3,465)             (3,465)  
Foreign currency translation adjustment (2,312)             (2,312)  
Net income 6,201           6,201    
Ending balance (in shares) at Mar. 31, 2020       29,510,161 18,000,000       2,101,795
Ending balance at Mar. 31, 2020 432,177     $ 3 $ 2 136,591 320,660 (13,291) $ (11,788)
Redeemable non-controlling interests, beginning balance at Dec. 31, 2020 38,850                
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Tax equity financing fees (17)                
Distributions to redeemable non-controlling interests (453)                
Accretion of tax equity financing fees 31                
Net income 1,257                
Redeemable non-controlling interests, ending balance at Mar. 31, 2021 39,668                
Beginning balance (in shares) at Dec. 31, 2020   30,224,654 18,000,000 30,224,654 18,000,000       2,101,795
Beginning balance at Dec. 31, 2020 492,813     $ 3 $ 2 145,496 368,390 (9,290) $ (11,788)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Equity offering, net of offering costs of $6,284 (in shares)       2,875,000          
Equity offering, net of offering costs of $6,284 120,216         120,216      
Exercise of stock options (in shares)       166,271          
Exercise of stock options 1,386         1,386      
Stock-based compensation expense 766         766      
Unrealized gain (loss) from interest rate hedges, net 2,118             2,118  
Foreign currency translation adjustment 413             413  
Accretion of tax equity financing fees (31)           (31)    
Net income 11,174           11,174    
Ending balance (in shares) at Mar. 31, 2021   33,265,925 18,000,000 33,265,925 18,000,000       2,101,795
Ending balance at Mar. 31, 2021 $ 628,855     $ 3 $ 2 $ 267,864 $ 379,533 $ (6,759) $ (11,788)